S. A. Serik

444 total citations
9 papers, 7 citations indexed

About

S. A. Serik is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, S. A. Serik has authored 9 papers receiving a total of 7 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in S. A. Serik's work include MicroRNA in disease regulation (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Circular RNAs in diseases (2 papers). S. A. Serik is often cited by papers focused on MicroRNA in disease regulation (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Circular RNAs in diseases (2 papers). S. A. Serik collaborates with scholars based in . S. A. Serik's co-authors include T. Ovrakh and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and Atherosclerosis.

In The Last Decade

S. A. Serik

4 papers receiving 6 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. A. Serik 2 4 3 3 3 2 9 7
Jiří Laštůvka Czechia 3 4 1.0× 3 1.0× 4 1.3× 2 0.7× 1 0.5× 5 13
Alexander Klabník Slovakia 2 6 1.5× 3 1.0× 4 1.3× 5 1.7× 4 9
M. Tzekova Bulgaria 3 5 1.3× 7 2.3× 2 0.7× 3 1.0× 2 1.0× 6 19
Ignacio Rodríguez Briones Taiwan 1 8 2.0× 2 0.7× 3 1.0× 3 1.0× 1 0.5× 2 9
Anastasia Kytölä Finland 2 4 1.0× 3 1.0× 4 1.3× 1 0.3× 1 0.5× 2 8
T. Ovrakh India 2 3 0.8× 1 0.3× 2 0.7× 2 0.7× 2 1.0× 4 5
Arvind R. Cavale India 2 3 0.8× 4 1.3× 4 1.3× 1 0.5× 3 7
Peter Olexa Slovakia 2 2 0.5× 6 2.0× 2 0.7× 2 0.7× 2 1.0× 5 13
Aurimas Kudzinskas United Kingdom 2 6 1.5× 3 1.0× 2 0.7× 4 2.0× 4 11
C. Axthelm Germany 2 3 0.8× 4 1.3× 2 0.7× 2 7

Countries citing papers authored by S. A. Serik

Since Specialization
Citations

This map shows the geographic impact of S. A. Serik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. A. Serik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. A. Serik more than expected).

Fields of papers citing papers by S. A. Serik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. A. Serik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. A. Serik. The network helps show where S. A. Serik may publish in the future.

Co-authorship network of co-authors of S. A. Serik

This figure shows the co-authorship network connecting the top 25 collaborators of S. A. Serik. A scholar is included among the top collaborators of S. A. Serik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. A. Serik. S. A. Serik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
3.
Serik, S. A., et al.. (2022). Modern Approaches to Treatment of Chronic Heart Failure in Patients with Type 2 Diabetes Mellitus. Ukraïnsʹkij žurnal medicini bìologìï ta sportu. 7(1). 14–31.
4.
5.
Serik, S. A., et al.. (2021). Atrial fibrillation in diabetic patients.. 2021(2). 103–117. 1 indexed citations
6.
7.
Serik, S. A., et al.. (2020). Circulating miсroRNAs in patients with ischemic heart disease with type 2 diabetes mellitus. SHILAP Revista de lepidopterología. 0(3).
8.
Ovrakh, T., et al.. (2017). [IMPACT OF ATORVASTATIN AND ROSUVASTATIN ON RESIDUAL ON-CLOPIDOGREL TREATMENT PLATELET REACTIVITY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND TYPE 2 DIABETES MELLITUS AFTER ACUTE CORONARY SYNDROME].. PubMed. 7–14. 3 indexed citations
9.
Serik, S. A., et al.. (2002). [Proinflammatory cytokines and soluble intercellular adhesion molecule-1 in ischemic heart disease].. PubMed. 42(9). 12–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiří Laštůvka Breakdown of academic impact, for papers by Alexander Klabník Breakdown of academic impact, for papers by M. Tzekova Breakdown of academic impact, for papers by Ignacio Rodríguez Briones Breakdown of academic impact, for papers by Anastasia Kytölä Breakdown of academic impact, for papers by T. Ovrakh Breakdown of academic impact, for papers by Arvind R. Cavale Breakdown of academic impact, for papers by Peter Olexa Breakdown of academic impact, for papers by Aurimas Kudzinskas Breakdown of academic impact, for papers by C. Axthelm
Rankless by CCL
2026